Eyenovia Surprises With $50m Foray Into Cryptocurrency, Reveals Validator Node Ambitions
Eyenovia’s bold $50 million leap into cryptocurrency challenges traditional pharmaceutical norms. Can this dual strategy reshape its future? The answer might surprise you.
